Ascites is a condition distinguished by formation of excess fluid within abdominal cavity, especially within peritoneal cavity. This causes when body is not able to evacuate fluids. When the ascites ...

ASCITES is a problem frequently encountered and often unsatisfactorily treated. An adjunct in the therapy of ascites has been tried in a limited number of cases and has seemed sufficiently helpful to ...

"Ascites in decompensated cirrhosis is a poor prognostic indicator, with a 50% 2-year survival, worsening significantly to 20% to 50% at 1 year when the ascites becomes refractory to medical therapy." ...

THE problem of the accumulation of fluid in the peritoneal cavity in association with cirrhosis of the liver has for many years presented a challenge to the surgeon, since it has always been tempting ...

BOTHELL, Wash. and CHICAGO, Jan. 4, 2013 -- PharmaIN Corporation and LAT Pharma LLC today announced that the US Food and Drug Administration (FDA) has granted their request for orphan-drug designation ...

LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature ...

Deferral of rectal surgery following a continued response to preoperative chemoradiotherapy (Watch and Wait) study: A phase II multicenter study in the United Kingdom. Background: In 2009 the ...

Dose-intensified rechallenge with temozolomide: One week on/one week off versus 3 weeks on/one week off in patients with progressive or recurrent glioblastoma. Background: The trifunctional anti-EpCAM ...

Ascites is a common complication of cirrhosis of the liver. Build-up of fluid causes the abdomen to swell and may lead to discomfort, difficulty breathing, fatigue, nausea and poor appetite. Treatment ...

Launch Offers Prolonged Puncture-free Survival and Delayed Deterioration of Quality of Life to Patients Who Are Ineligible for Systemic Anticancer Therapy This Marks Another Milestone for Pharmanovia, ...